All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for ULTRAGENYX PHARMACEUTICAL, INC. · Biopharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income · posted Oct 17, 2025

Official filing document

Bills named in this filing 5

HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Health Issues

Issues relating to rare disease and patient access. H.R.1262/S. 932 - Give Kids a Chance Act of 2025. H.R.1509/S. 752 - Accelerating Kids Access to Care Act of 2025. H.R. 1/PL 119-21 - One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.